A new study from Ontario has found a significant increase in prescriptions for stimulant medications used to treat attention-deficit hyperactivity disorder (ADHD). The research, published in JAMA Network Open, shows that prescriptions have risen especially sharply among adults and women. The authors say clearer clinical guidance is needed to ensure these medicines are used safely and appropriately, particularly because stimulants can carry risks such as effects on the heart.

ADHD is a neurodevelopmental disorder that affects one’s focus, impulse, and daily functioning. It is considered common and affects approximately five per cent of the general population.

ADHD prescriptions rose 157 per cent between 2015 and 2023 Researchers from SickKids and North York General Hospital reviewed dat

See Full Page